Vantus Wealth’s Merck MRK Stock Holding History

Vantus Wealth’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$675K	Buy	+5,250	New	+$615K	0.36%	83
2025 Q4	$463K	Buy	+4,397	New	+$413K	0.34%	90

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vantus Wealth's MRK Position: Q2 2026 in Review

Vantus Wealth opened a new position in Merck (MRK) in Q2 2026: 5,250 shares worth $675K. The stake represents 0.36% of the portfolio and ranks #83 among its holdings. This is a return to the name: Vantus Wealth previously reported a position in MRK as recently as Q4 2025.

Vantus Wealth first reported a position in MRK in Q4 2025 and has held it in 2 quarters since. 3,828 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Vantus Wealth held 5,250 shares of Merck worth $675K as of Q2 2026.
Merck was a new Vantus Wealth position in Q2 2026.
Merck made up 0.36% of Vantus Wealth's portfolio in Q2 2026, its #83 holding.
Vantus Wealth first reported a position in Merck in Q4 2025 and has held it in 2 quarters since.
3,828 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Vantus Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.